Revenues and Accounts Receivable (Tables)

12 Months Ended

Dec. 31, 2023

Revenues And Accounts Receivable [Abstract]

Schedule of Contract Balances

The following table presents the Company’s contract balances as of December 31:

	2023		2022
Contract assets	$	51,629	$	52,403
Contract liabilities (Note 10)		8,132		18,549

Schedule of Accounts Receivable, Net

Accounts Receivable, Net—Accounts receivable, net as of December 31, consisted of the following:

	2023			2022
Accounts receivable, invoiced	$	115,064		$	95,055
Accounts receivable, other		20			1,571
Allowance for doubtful accounts		(2,724	)		(1,915	)
Accounts receivable—net	$	112,360		$	94,711

Schedule of Allowance for Doubtful Accounts

The allowance for doubtful accounts consisted of the following:

	Beginning Balance		Bad Debt Expense (Recovery)				Charged to Allowance			Other			Ending Balance
Year ended December 31, 2023	$	1,915	$	3,142		(1)	$	(2,333	)	$	—		$	2,724
Year ended December 31, 2022		4,581		(1,097	)			(1,696	)		127	(2)		1,915
Year ended December 31, 2021		4,265		1,135				(1,548	)		729	(2)	$	4,581

(1)Amount includes $2.2 million of current expected losses on the Discontinued Specialty Lab promissory note receivable as described in Note 19.

(2)This amount consists of additions to the allowance due to business acquisitions.